All articles tagged with #neuroprotection
Originally Published 11 days ago — by ScienceAlert
A new study shows that the drug candidate P7C3-A20 can restore cognitive functions, reduce brain damage, and repair the blood-brain barrier in mice with advanced Alzheimer's, suggesting potential for future human treatments by restoring NAD+ levels, though more research is needed.
Originally Published 24 days ago — by ScienceAlert
A small Brazilian study found that microdoses of cannabis extract may help stabilize cognitive decline in patients with mild Alzheimer's disease, showing potential for a new therapeutic approach without psychoactive effects. Further research with larger samples is needed to confirm these findings.
Originally Published 1 month ago — by ScienceAlert
A study suggests that doxycycline, an antibiotic used for acne, may be linked to a 30% lower risk of developing schizophrenia in adolescents, possibly due to its effects on immune response and inflammation, though further research is needed to confirm causality.
Originally Published 1 month ago — by ScienceAlert
A new study suggests that specific immune cells in the brain called microglia can switch to a protective state that may prevent or slow Alzheimer's disease progression, opening potential avenues for immunotherapy. The research highlights the importance of microglia's plasticity and their role in combating harmful protein buildup associated with Alzheimer's, with implications for future treatments targeting immune cell states.
Originally Published 2 months ago — by Nature
The study investigates how lymphoid gene expression supports neuroprotective functions of microglia in the human brain, particularly in the context of Alzheimer's disease, using post-mortem samples, induced pluripotent stem cells, and mouse models to explore microglial roles and gene regulation.
Originally Published 3 months ago — by Neuroscience News
Researchers have identified two compounds, K102 and K110, capable of repairing the myelin sheath damaged by multiple sclerosis, showing promise for reversing nerve injury and advancing toward human clinical trials.
Originally Published 4 months ago — by Neuroscience News
Scientists discovered that disrupting the toxic NMDAR/TRPM4 protein complex with the molecule FP802 in mice can slow Alzheimer's progression, preserve cognitive functions, and reduce amyloid buildup, offering a promising new therapeutic approach for neurodegenerative diseases.
Originally Published 4 months ago — by Times of India
Emerging research highlights the importance of the full vitamin B complex, including B1, B2, B3, B5, B7, and B9, in supporting brain energy, neurotransmitter synthesis, and potentially slowing cognitive decline. Incorporating B-rich foods like whole grains, leafy greens, nuts, and eggs into your diet can help maintain brain health without supplements, but always consult a healthcare professional before making dietary changes.
Originally Published 5 months ago — by Medical News Today
A new study suggests that low levels of lithium in the brain are linked to Alzheimer's disease, with findings indicating that lithium naturally occurs in the brain and plays a crucial role in its function. Reduced lithium levels may serve as an early warning sign and a potential target for treatment, as supplementing lithium in animal models reversed brain damage and improved memory, highlighting a promising new approach for Alzheimer's prevention and therapy.
Originally Published 5 months ago — by Marijuana Moment
A large-scale U.S. government-funded study suggests that marijuana use may be linked to enhanced cognitive abilities and brain health in older adults, potentially slowing neural aging processes and preserving cognitive function, though more research is needed to understand the mechanisms involved.
Originally Published 5 months ago — by Medical News Today
A recent study suggests that GLP-1 agonists may offer better protection against dementia in people with type 2 diabetes compared to metformin, with findings indicating a significantly lower risk of developing dementia and Alzheimer’s disease among GLP-1 users. The research highlights the potential neuroprotective benefits of GLP-1 medications, which could influence future treatment strategies for diabetes and cognitive decline.
Originally Published 5 months ago — by SciTechDaily
Recent studies presented at SNIS suggest that GLP-1 receptor agonists like Ozempic, commonly used for diabetes and obesity, may have neuroprotective effects, including reducing stroke risk and improving survival and recovery outcomes after stroke and brain hemorrhages.
Originally Published 5 months ago — by News-Medical
Recent research suggests that creatine may enhance brain resilience and cognitive function by supporting energy pathways and promoting the release of myokines through the muscle-brain axis, potentially offering neuroprotective benefits beyond its traditional role in muscle building.
Originally Published 5 months ago — by SciTechDaily
A new drug called GAI-17 developed in Japan can protect mouse brains from stroke damage even when administered up to six hours after the event, by inhibiting a protein involved in neuron death, with potential applications for other neurological diseases like Alzheimer's, and showing no significant side effects.
Originally Published 6 months ago — by PsyPost
A mouse study suggests that creatine supplementation may help slow brain aging and improve memory by increasing the activity of the brain enzyme CK-BB, which supports energy metabolism, and could potentially be a nutritional strategy to preserve cognitive function in aging.